Hypoxia-induced angiopoietin-like protein 4 as a clinical biomarker and treatment target for human prostate cancerShinro Hata(Oita University), Hiromitsu Mimata(Oita University)Oncology ReportsJanuary 1, 201710.3892/or.2017.5669Cited by 31SaveCiteExport RISWatch citationsRelated PapersMetallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells|Oncology Reports|2007|70Dual targeting of heat shock proteins 90 and 70 promotes cell death and enhances the anticancer effect of chemotherapeutic agents in bladder cancer|Oncology Reports|2014|47Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells|Oncology Reports|2014|28